Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: CDER Approves Its First Two Novel Agents Of 2019

Feb 11 2019

• By Michael Cipriano

Keeping Track Feature image

Related Content

Keeping Track: DMD, RMAT, HIV, BTDs, Tc-99m – FTW

Feb 11 2018

No Safety Shortcuts Under Breakthrough Designation, Synthetic Biologics Finds

Apr 26 2018

Keeping Track: FDA's Review Actions Carry On During Shutdown

Jan 20 2019

Keeping Track: Bad News For Bristol And Lilly, Good News For TG Therapeutics

Jan 27 2019

Keeping Track: J&J Esketamine, Sanofi Caplacizumab Lead Off September Submissions; US FDA Says No To Nucala

Sep 10 2018

Keeping Track: FDA Approves First Generic Advair, But Alkermes And Sunovion Land CRLs

Feb 02 2019

Keeping Track: A Diverse Array Of Approvals, A CRL For Evolus' Botox Competitor, And Coherus Refiles Neulasta Biosimilar

May 20 2018

Novo Outbid As Sanofi Agrees €3.9bn Ablynx Acquisition

Jan 29 2018

Incyte's Jakafi 1st drug OK'd in polycythemia vera

Dec 05 2014

Merck's relebactam dubbed qualified infectious disease product

Sep 05 2014

Sanofi Pasteur, AstraZeneca Link To Develop MEDI8897 Infant RSV Vaccine

Mar 03 2017

Merck & Co Expands C Diff Franchise With US Zinplava Approval

Oct 24 2016

Synthetic Biologics’ Ribaxamase Setback Shows Difficulty Of C. Difficile Development

Apr 23 2018

Merck Looks To Add Pneumonia To Zerbaxa Label; Market Value Not Clear

Sep 12 2018

Allergan Aesthetic Medicines Head Moatazedi Moves To Emerging Competitor Evolus

May 08 2018

Sobi Taps AstraZeneca's RSV Therapies, Both Current And Future, For US Expansion

Nov 13 2018

Incyte Will File Jakafi For Acute GVHD In US Based On Phase II Success

Jun 22 2018

Cablivi CHMP Backing Helps Validate Sanofi's €3.9bn Ablynx Purchase

Jun 29 2018

Keeping Track: FDA Approves Epclusa, Designates Four Breakthrough Therapies, Files Burst Of Applications

Jul 04 2016

Related Companies

Evolus, Inc.

Allergan plc

Sanofi

Genentech, Inc.

Zogenix, Inc.

Incyte Corporation

Merz Pharmaceuticals GmbH

Immunomedics, Inc.

Alkermes plc

Ablynx N.V.

Roche Holding AG

Seagen Inc.

GW Pharmaceuticals plc

Biocodex

Theriva Biologics, Inc.

Johnson & Johnson

Merck & Co., Inc.

Sanofi

Swedish Orphan Biovitrum AB

Additional Topics

United States Drug Review Regulation BioPharmaceutical

More from Product Reviews

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window